Connecting aging biology and inflammation in the omics era
Open accessThe DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index, and 1 are not checked yet; 134 of the 214 sources its claims cite were checked for support.
Abstract
Aging is characterized by the accumulation of damage to macromolecules and cell architecture that triggers a proinflammatory state in blood and solid tissues, termed inflammaging. Inflammaging has been implicated in the pathogenesis of many age-associated chronic diseases as well as loss of physical and cognitive function. The search for mechanisms that underlie inflammaging focused initially on the hallmarks of aging, but it is rapidly expanding in multiple directions. Here, we discuss the threads connecting cellular senescence and mitochondrial dysfunction to impaired mitophagy and DNA damage, which may act as a hub for inflammaging. We explore the emerging multi-omics efforts that aspire to define the complexity of inflammaging - and identify molecular signatures and novel targets for interventions aimed at counteracting excessive inflammation and its deleterious consequences while preserving the physiological immune response. Finally, we review the emerging evidence that inflammation is involved in brain aging and neurodegenerative diseases. Our goal is to broaden the research agenda for inflammaging with an eye on new therapeutic opportunities.
Verified 2026-10-05 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
This review argues that inflammaging arises from intertwined aging hallmarks—cellular senescence, mitochondrial dysfunction, impaired mitophagy, and DNA damage—and can be dissected with multi-omics approaches. It surveys evidence linking these processes to age-related disease and brain aging, while highlighting unresolved questions about biomarkers, causality, and therapeutic targeting.
Key findings
- Cellular senescence and the SASP are presented as key drivers of local and systemic inflammation, contributing to conditions such as atherosclerosis, osteoarthritis, cancer, pulmonary fibrosis, Alzheimer’s disease, Parkinson’s disease, and insulin resistance; senescent immune cells may also drive aging of solid organs.
- Mitochondrial dysfunction is described as a nexus linking impaired mitophagy, DNA damage, NAD+ depletion, and inflammatory pathways including NLRP3, cGAS/STING, and NF-κB; DNA of mammalian cells experiences over 10^5 modifications per day, many ROS-related single-strand breaks.
- Multi-omics studies are beginning to resolve inflammation subtypes: a PCA of 19 proteins identified two immune-signaling components, and an inflammatory age score derived from 73 plasma and CSF proteins accounted for approximately 40% of the variance in chronological age and was associated with AD dementia, AD pathology, and lower cognition.
- Genetic contributions to immune traits vary widely: one large-scale GWAS found a median heritability of 37% for a broad set of immune cell types and traits, with some phenotypes as high as 96%; serum cytokine/chemokine heritability ranges from 50% to 90% in healthy twins aged 8–82 years, and TNF-α variance explained by genome-wide SNP data was more than 70% after fungal stimulation and more than 50% after LPS stimulation.
Methods
- Narrative review; no primary experimental design, sample, or statistical analysis is reported.
- Synthesizes evidence from animal models, human cohort studies, clinical trials, multi-omics/proteomic platforms, single-cell RNA sequencing, and genetic studies.
- Thematically organized around cellular senescence/SASP, age-related mitochondrial dysfunction, multi-omics approaches to inflammaging, and inflammation in brain aging and neurodegenerative disease.
Limitations
- The paper states that the robustness and generalizability of developed inflammatory signatures are not ready for clinical applications; that a causal role for cellular senescence in neurodegenerative disease has yet to be established; that the extent to which neuroinflammation is protective or pathogenic is unknown; and that attempts to distinguish beneficial from pathological senescence at proteome, transcriptome, and functional levels have not been successful.
- The paper also notes limitations of current large-scale proteomic approaches, including platform-specific measurement variation, incomplete target validation, a bias toward secreted proteins, and limited breadth of protein measurement.
- Evident from the text: this is a narrative review without a systematic search strategy or meta-analysis, and its topic selection is explicitly focused on a few areas rather than being exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
77 Valid · 2 Not valid · 47 Not checked · 25 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Aging is characterized by the accumulation of damage to macromolecules and cell architecture that triggers a proinflammatory state in blood and solid tissues, termed inflammaging.”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Partly supportedcites [1] Ferrucci L et al Measuring biological aging in humans: a quest Aging Cell 2020 19 2 e13080 31833194 PMC6996955 sourceExperimental — accuracy not yet measured
The closest body statement (CONNECTING THE BIOLOGY OF AGING WITH AGE‐ASSOCIATED MULTIMORBIDITY) says the hallmarks of aging 'directly or indirectly cause an inflammatory state, suggesting that the pro‐inflammatory state observed in many older persons may reflect the burden of biological aging' — i.e. a hedged inference credited to Ferrucci et al. 2005, Franceschi & Campisi 2014 and Fulop et al. 2018, not the assertive causal statement of the claim. The damage half is supported (INTRODUCTION/Figure 1: 'Over time, damage accumulates that is not fully compensated by resilience'; Proteostasis: 'repair, recycling, and elimination of damaged macromolecules/organelles… maintaining cell integrity'), and blood-side inflammation is covered via circulating IL‑6 and SASP proteins spilling over from tissues, but our copy nowhere defines this state as 'inflammaging' — the word occurs only inside reference titles (refs 75, 79, 82). So the label 'termed inflammaging' and the flat causal phrasing are not supported by this paper. (LLM, conf=0.72)
- Partly supportedcites [2] Ferrucci L et al Time and the metrics of aging Circ Res 2018 123 7 740 744 10.1161/CIRCRESAHA.118.312816 30355074 PMC6205734 sourceExperimental — accuracy not yet measured
Ferrucci et al.'s 'Time and the Metrics of Aging' (Hallmarks or Pillars of Aging as Drivers of Age-Related Diseases) does treat inflammation as downstream of other aging mechanisms and a strong risk factor for cardiovascular disease and multi-morbidity, and the Temporal Hierarchy / Building Connections sections describe accumulating molecular and cellular damage (misfolded proteins, damaged mitochondria, DNA damage) outpacing resilience mechanisms — so the damage-accumulation half of the claim is in our copy. However, the causal chain is framed as a hypothesis ('The hypothesis of a common mechanism is consistent with inflammation being a "pillar" that is downstream of other mechanisms of aging'), not as the stated characterization of aging the citing sentence asserts, and our copy never uses the term 'inflammaging' nor describes a proinflammatory state specifically 'in blood and solid tissues' (the only tissue-inflammation passage attributes inflammatory cytokine production to senescent cells and notes it derives largely from animal models, untranslato to humans). The unsupported parts are the definitive causal wording, the 'blood and solid tissues' specification, and the coinage/attribution of the label 'inflammaging' to this paper. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“With aging, resilience mechanisms become less effective at repairing or removing damage and preventing its deleterious effects on health (2).”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Supportedcites [2] Ferrucci L et al Time and the metrics of aging Circ Res 2018 123 7 740 744 10.1161/CIRCRESAHA.118.312816 30355074 PMC6205734 source
The section 'Building Connections Between the Metrics of Aging' (p. of passage 1) states directly that resilience mechanisms perform maintenance and repair and that 'their efficiency eventually fades and allows entropy to result in frailty and death.' 'The Temporal Hierarchy of the Metrics of Aging' (passage 2) reinforces this by listing repair/removal processes (chaperone refolding, autophagy, mitophagy, DNA repair, senescence/apoptosis, stem-cell replacement) and noting that when accumulating damage overcomes these compensatory mechanisms, effects on phenotype become progressively evident, i.e., deleterious health effects. The Summary (passage 8) adds that functional aging occurs only when resilience mechanisms are exhausted. The paraphrase matches the source in content and qualifiers. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although increased levels of inflammatory mediators (mostly IL-1, IL-6, TNF-α, and its receptors) are detected in all elderly individuals, higher levels of these biomarkers are associated with increased risk for many chronic conditions, including dementia, disability, and physical frailty.”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Partly supportedcites [4] Ferrucci L Fabbri E Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty Nat Rev Cardiol 2018 15 9 505 522 10.1038/s41569-018-0064-2 30065258 PMC6146930 sourceExperimental — accuracy not yet measured
The ‘Risk factors and causes of inflammageing’ section lists IL-1, IL-6, TNF and soluble TNF receptors among age-associated inflammatory markers, but says high levels are detected in the majority of older individuals, not all. The ‘Inflammation and age-related frailty’ section also links inflammation to dementia, disability and features of frailty. Page numbers are not provided in our copy’s passages. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hallmarks of immune aging are (a) a state of proinflammatory activation characterized by high circulating levels of proinflammatory cytokines — such as IL-6 and TNF-α — and localized tissue inflammation”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Supportedcites [6] Bektas A et al A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing 2020 17 23 10.1186/s12979-020-00196-8 32849908 PMC7443812 source
The 'COVID-19 and inflammaging' section states that dysfunction of the hallmarks of aging converges into a pro-inflammatory response and that inflammaging 'is characterized clinically by higher levels of several inflammatory blood biomarkers, including CRP, IL-6, IL-18, and TNF', i.e. the elevated circulating IL-6/TNF part of the claim. The tissue component is covered by the same sections and Fig. 1/Fig. 2 captions, which describe accumulation of senescent cells in various tissues secreting SASP pro-inflammatory cytokines that spill into the circulation, and by 'COVID-19 and mechanisms of inflammaging in older individuals', which describes the aging immune system as maintaining 'a permanent state of mild activation' combined with a chronic pro-inflammatory state (immunosenescence). The citing sentence's label 'hallmarks of immune aging' is the authors' framing; the paper speaks of hallmarks of aging/inflammaging, but the attributed content matches. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The immune system undergoes numerous and profound changes with aging, which are extensively reviewed elsewhere (3–5).”
§ Connecting aging biology and inflammation in the omics era > Abstract
What the sources say
- Supportedcites [3] Franceschi C et al Inflammaging: a new immune-metabolic viewpoint for age-related diseases Nat Rev Endocrinol 2018 14 10 576 590 10.1038/s41574-018-0059-4 30046148 source
The Introduction (p. 5) describes age-related chronic activation of the innate immune system and several cellular and molecular mechanisms involved in inflammaging. This supports the broad claim that the immune system changes substantially with age. (LLM, conf=0.87)
- Supportedcites [4] Ferrucci L Fabbri E Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty Nat Rev Cardiol 2018 15 9 505 522 10.1038/s41569-018-0064-2 30065258 PMC6146930 source
The ‘Risk factors and causes of inflammageing’ section states that ageing is associated with immune dysregulation and describes changes in inflammatory markers. Its subsections on intrinsic immune-cell defects and cellular senescence describe further age-related changes in lymphocytes, supporting the broad claim. (LLM, conf=0.90)
- Supportedcites [5] Furman D et al Chronic inflammation in the etiology of disease across the life span Nat Med 2019 25 12 1822 1832 10.1038/s41591-019-0675-0 31806905 PMC7147972 source
The section “Chronic inflammation and the immune response to acute challenges” (page not provided) describes several age-related immune changes: increasing systemic chronic inflammation, reduced components of the immune response, greater susceptibility to viral infection, and weaker vaccine responses. These support the citing sentence’s broad statement that the immune system changes substantially with aging. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
87 more claims · 60 with their cited sources checked
Create a free account to see all 151 claims and to verify the 80 references still open.
- It may state two separate claims as one. 55
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the ML-defined senescent populations were enriched for other senescence signatures,12–18 although with some lineage-specific disparities for some lists (Figure 4G)”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [13]
Experimental — accuracy not yet measured
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“1172/JCI158448 Efforts to characterize inflammation in humans have relied on one or a few inflammatory proteins, with IL-6, TNF-α, and CRP being the most widely used (5).”
BackgroundSelf-citationAutophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Self-citationInflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“Cellular senescence can be initiated by multiple intrinsic and extrinsic nonlethal stresses, including genotoxic, oncogenic, mitochondrial, oxidative, inflammatory, paracrine signaling, and others (11).”
BackgroundGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005 · cited 2×
“NF-κB activation drives multiple pleiotropic effects, including enhancing the transcription of proinflammatory mediators, such as TNF-α and IL-6, that regulate both innate and adaptive immunity (95).”
BackgroundGillet, L. C., Navarro, P., Tate, S., Röst, H., Selevsek, N., Reiter, L., Bonner, R., & Aebersold, R. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.016717 · Cited by 2,877
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Chronic inflammation and the hallmarks of aging
Baechle, J. J., Chen, N., Makhijani, P., Winer, S., Furman, D., & Winer, D. A. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101755 · Cited by 471
“Meanwhile, reduced Sirt1 reduces mitochondrial biogenesis, reduced mitochondrial Sirt3 reduces mitochondrial antioxidant and repair systems, and reduced NAD þ may also impair Sirt2, enhancing NLRP3 inflammasome activity [22].”
BackgroundInfluentialSenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“Other potential sources of circulating biomarkers remain to be explored in detail in vivo, including senescence-associated extracellular vesicles (another bioactive component of the SASP 290 ) and senescent circulating lymphocytes 86,290–294 .”
Self-citationSingh, A., Schurman, S. H., Bektas, A., Kaileh, M., Roy, R., Wilson, D. M., Sen, R., & Ferrucci, L. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041197 · Cited by 182
Self-citationCembrowska-Lech, D., Krzemińska, A., Miller, T., Nowakowska, A., Adamski, C., Radaczyńska, M., Mikiciuk, G., & Mikiciuk, M. (2023) · Biology · doi:10.3390/biology12101298 · Cited by 175
“Provides objective and consistent analyses [29,30].”
BackgroundInfluentialThe role of peripheral inflammatory insults in Alzheimer’s disease: a review and research roadmap
Walker, K. A., Le Page, L. M., Terrando, N., Duggan, M. R., Heneka, M. T., & Bettcher, B. M. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00627-2 · Cited by 113
“Given that there are hundreds of secreted immune and inflammatory proteins in circulation, analyses of the larger inflammatory proteome, alongside pathway and network analyses, will likely be needed to yield more specific insights about the immune pathway- and disease stage-specific role of inflammatory proteins in th…”
BackgroundSelf-citationAhuja, S. K., Manoharan, M. S., Lee, G. C., McKinnon, L. R., Meunier, J. A., Steri, M., Harper, N., Fiorillo, E., Smith, A. M., Restrepo, M. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38238-6 · Cited by 117
Jurcău, M. C., Jurcău, A., Cristian, A., Hogea, V. O., Diaconu, R. G., & Nunkoo, V. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910535 · Cited by 104
“…receptor-associated factor 4, which facilitates nicotinamide adenine dinucleotide phosphate hydrogen oxidase activity and leads to ROS production [345], or via inducible nitric oxide synthase, which reduces DNA methyltransferase 1 and leads to DNA damage and hypomethylation [346]. b. Telomere…”
BackgroundEvans, D. S., Young, D., Tanaka, T., Basisty, N., Bandinelli, S., Ferrucci, L., Campisi, J., & Schilling, B. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad265 · Cited by 78
“Cellular senescence is a driver of both physiologically beneficial phenotypes and age-related pathologies owing to the heterogeneous phenotypes of senescent cells that inhabit an organism or tissue, or “senotype” (45), which is dependent on biological context and environmental factors.”
BackgroundSelf-citationA multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)
Li, F., Tian, J., Zhang, L., He, H., & Song, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117225 · Cited by 84
Li, H., Cai, R., Zhou, Y., Jiang, Y., & Tan, S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03563-8 · Cited by 79
Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease
Forman, D. E., Kuchel, G. A., Newman, J. C., Kirkland, J. L., Volpi, E., Taffet, G. E., Barzilai, N., Pandey, A., Kitzman, D. W., Libby, P., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.05.038 · Cited by 71
Self-citationOrkaby, A. R., Dushkes, R., Ward, R. E., Djoussé, L., Buring, J. E., Lee, I.-M. M., Cook, N. R., LeBoff, M. S., Okereke, O. I., Copeland, T., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.31206 · Cited by 64
“1,30,31 Observational data have shown an association between malnutrition and increased risk of frailty, and supplementation with micronutrients and macronutrients has been hypothesized as a potential approach for both prevention and treatment of frailty.”
Zhang, W., Xu, M., Chen, F., Su, Y., Yu, M., Xing, L., Chang, Y. E., & Yan, T. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114474 · Cited by 60
Markers of aging: Unsupervised integrated analyses of the human plasma proteome
Coenen, L., Lehallier, B., de Vries, H. E., & Middeldorp, J. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1112109 · Cited by 53
“, 2019), disease-associated molecules or pathogens are often elevated at later ages (Walker et al., 2022), leading to a chronic state of low-grade inflammation known as ‘inflammaging’.”
BackgroundKarpuzoglu, E., Holladay, S. D., & Gogal, R. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1704203 · Cited by 66
Wahl, D., Risen, S. J., Osburn, S. C., Emge, T., Sharma, S., Gilberto, V. S., Chatterjee, A., Nagpal, P., Moreno, J. A., & LaRocca, T. J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03182-9 · Cited by 44
“NF-κB and NLRP3 are central mediators of age-related inflammation (i.e., “inflammaging”), neuroinflammation, innate immune responses and cytokine release, including in the brain [6, 7, 21, 22].”
BackgroundDual cognitive and mobility impairments and future dementia ‐ Setting a research agenda
Tian, Q., Montero‐Odasso, M., Buchman, A. S., Mielke, M. M., Espinoza, S. E., DeCarli, C. S., Newman, A. B., Kritchevsky, S. B., Rebok, G. W., Resnick, S. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12905 · Cited by 44
Self-citationHussain, M., Chu, X., Sahbaz, B. D., Gray, S. H., Pekhale, K., Park, J. H., Croteau, D. L., & Bohr, V. A. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.262 · Cited by 49
Neuroinflammaging: A Tight Line Between Normal Aging and Age-Related Neurodegenerative Disorders
Soraci, L., Corsonello, A., Paparazzo, E., Montesanto, A., Piacenza, F., Olivieri, F., Gambuzza, M. E., Savedra, E. V., Marino, S., Lattanzio, F., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.1001 · Cited by 81
“In this framework, it is relevant to disentangle the molecular pathways that fuel inflammaging, focusing on genetic, epigenetic, and environmental factors and their complex interactions [7, 11, 12].”
BackgroundAn, S., Qin, J. G., Gong, X., Li, S., Ding, H., Zhao, X. L., He, H., Zhou, L., Deng, X., & Chu, X. (2024) · Nutrients · doi:10.3390/nu16234164 · Cited by 46
“Aging cells, in turn, subsequently further aggravate metabolic disorders and inflammation, thus causing degenerative diseases (such as CVD, sarcopenia, cancer, etc.) and accelerating the aging process [42].”
Tian, Q., Bilgel, M., Walker, K. A., Moghekar, A., Fishbein, K. W., Spencer, R. G. S., Resnick, S. M., & Ferrucci, L. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13388 · Cited by 46
Self-citationImmunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 50
Mitochondria-driven inflammation: a new frontier in ovarian ageing
Ju, W., Yan, B., Li, D., Lian, F., & Xiang, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06966-6 · Cited by 47
“Recent studies have high-lighted mitochondrial dysfunction and chronic low-grade inflammation as central drivers in this process [9, 18, 247].”
The mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Jin, S., Lü, W., Zhang, J., Zhang, L., Tao, F., Zhang, Y., Hu, X., & Liu, Q. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.09.005 · Cited by 44
Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Chen, S., Tan, Y., & Tian, L. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02539-z · Cited by 40
“Nevertheless, how to precisely assess in fl amm-aging in psychotic disorders remains an unsettled question and would require standardized procedure borrowed from other disciplines to achieve consensual fi ndings [127].”
BackgroundSchwartzman, J. D., McCall, M., Ghattas, Y. S., Pugazhendhi, A. S., Wei, F., Ngo, C., Ruiz, J., Seal, S., & Coathup, M. J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122683 · Cited by 36
Neuron-specific isoform of PGC-1α regulates neuronal metabolism and brain aging
Souder, D. C., McGregor, E. R., Clark, J. P., Rhoads, T. W., Porter, T. J., Eliceiri, K. W., Moore, D. L., Puglielli, L., & Anderson, R. M. (2025) · Nature Communications · doi:10.1038/s41467-025-57363-y · Cited by 35
“…identi fi cation of immune, in fl ammatory, and neurological pathways responsive to aging and age-related conditions is consistent with prior studies 20,21 and indicates that the environment of the aging brain is distinct from that of mature adult mice and that processes involved in neuronal…”
Xu, J., Wakai, M., Xiong, K., Yang, Y., Prabakaran, A., Wu, S. P., Ahrens, D., Molina‐Portela, M. D. P., Ni, M., Bai, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115403 · Cited by 48
Tian, Q., Lee, P. R., Yang, Q., Moore, A. Z., Landman, B. A., Resnick, S. M., & Ferrucci, L. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13413 · Cited by 28
Self-citationXie, S., & Wu, Q. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04808-7 · Cited by 35
“This would result in weakened immune function, and the inability to clear senescent cells and inflammatory factors, leading to a vicious cycle of inflammation and aging [44].”
BackgroundKacemi, R., & Campos, M. G. (2023) · Nutrients · doi:10.3390/nu15102413 · Cited by 29
Natural Modulators of Key Signaling Pathways in Skin Inflammageing
Ren, Q., Qu, L., Yuan, Y., & Wang, F. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s502252 · Cited by 33
The secretome of senescent monocytes predicts age-related clinical outcomes in humans
Olinger, B., Banarjee, R., Dey, A. K., Tsitsipatis, D., Tanaka, T., Ram, A., Nyunt, T., Daya, G. N., Peng, Z., Shrivastava, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00877-3 · Cited by 37
Self-citationMaintaining brain health across the lifespan
García‐García, I., Donica, O., Cohen, A. A., Gonseth, S., Heini, A. F., Nusslé, S. C., Pichard, C., Rietschel, E., Tanačković, G., Folli, S., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105365 · Cited by 28
“Gene expression controlled by NF-κ B, in turn, produces a further release of proinflammatory cytokines and it can activate the microglia, the CNS innate immune cells (Walker et al., 2022).”
Ki, M., Kim, D. H., Abdelhamid, M. A. A., & Pack, S. P. (2025) · Biosensors · doi:10.3390/bios15110737 · Cited by 35
Horvath, C. G., Jarabicová, I., Kura, B., Kaločayová, B., Faurobert, E., Davidson, S. M., & Adameová, A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119534 · Cited by 27
Li, P., Zhou, M., Wang, J., Tian, J., Zhang, L., Wei, Y., Yang, F., Xu, Y., & Wang, G. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s499473 · Cited by 31
Wei, D., Qu, C., Zhao, N., Li, S., Pu, N., Song, Z., & Tao, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102308 · Cited by 23
Galactomyces Ferment Filtrate Potentiates an Anti-Inflammaging System in Keratinocytes
Yan, X., Tsuji, G., Hashimoto-Hachiya, A., & Furue, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216338 · Cited by 20
“Oxidative stress is also a factor in senescence, as it induces the production of proinflammatory cytokines [6,71], which are involved in inflammaging [7,8,82].”
BackgroundMarcinek, D. J., & Ferrucci, L. (2024) · The Journal of Physiology · doi:10.1113/jp285040 · Cited by 23
“…the release of proinflammatory cytokines through activation of the NLRP3 inflammasome or the stimulator of interferon genes (STING) pathways that induce chronic inflammation (Chen et al., 2021; Lin et al., 2022; Masumoto et al., 2021; Qiu et al., 2022; Walker et al., 2022; Zhang et al., 2019).”
Self-citationPeriocular Aging Across Populations and Esthetic Considerations: A Narrative Review
Tao, B. K.-L., Butt, F. R., Dhivagaran, T., Balas, M., Nijhawan, N., Nassrallah, G. B., Hussain, A., & Ing, E. B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020535 · Cited by 25
Alzheimer’s disease transcriptional landscape in ex vivo human microglia
Kosoy, R., Fullard, J. F., Bendl, J. M., Kleopoulos, S. P., Shao, Z., Argyriou, S., Mathur, D. D., Psychogyiou, K., Malakates, P., Vicari, J. M., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02020-2 · Cited by 30
“In fact, expression of IFNα and IFNγ response genes tends to increase with age, which is consistent with aging-related inflammation 29 .”
Wennberg, A. M., Maher, B. S., Rabinowitz, J. A., Holingue, C., Felder, W. R., Wells, J. L., Munro, C. A., Lyketsos, C. G., Eaton, W. W., Walker, K. A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13070 · Cited by 19
Self-citationMahoney, S. A., Dey, A. K., Basisty, N., & Herman, A. B. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00352.2023 · Cited by 21
Self-citationFernandez, B., Passanisi, V. J., Ashraf, H. M., & Spencer, S. L. (2025) · Nature Communications · doi:10.1038/s41467-025-66836-z · Cited by 18
“Additionally, within a single population, we identi fi ed distinct senescence types, or senotypes 17 , with distinct geneexpressionpro fi les that resulted from different paths to senescence.”
Huang, X., Sang, Z., Liu, H., Yang, J., Wang, K., Qu, Y.-N., & Deng, H. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01669-9 · Cited by 21
“Research demonstrates that peripheral inflammation contributes to neuroinflammation in Parkin - son’s disease (PD) by compromising the BBB, promoting A1 astrocyte polarization, and increasing microglial activation, the chemokine receptor CCR2, into the brain.”
Energizing Mitochondria to Prevent Mobility Loss in Aging: Rationale and Hypotheses
Tian, Q., Lee, P. R., Walker, K. A., & Ferrucci, L. (2023) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000315 · Cited by 16
“Proinflammatory responses: Mitochondria recently have been considered as the hub for most inflammatory responses (34).”
BackgroundSelf-citationSex differences in plasma lipid profiles of accelerated brain aging
Tian, Q., Mitchell, B. A., Erus, G., Davatzikos, C. A., Moaddel, R., Resnick, S. M., & Ferrucci, L. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.05.013 · Cited by 18
Self-citationNguyen, N.-H. T., Phan, H. T., Le, P., Nguyen, L.-H. T., Thi, T. B., Phan, T.-P. T., Le, T. V., Dang, T. M., Phan, C.-N. L., Dang, T.-L. T., et al. (2024) · Trials · doi:10.1186/s13063-024-08128-3 · Cited by 18
“Therefore, inflammatory aging is an age-associated pathogenesis of numerous chronic diseases [22].”
BackgroundHuang, Y., Feng, J., Xu, J., Dong, L. F., Su, W., Li, B., Witwer, K. W., & Zheng, L. (2024) · Aging Cell · doi:10.1111/acel.14356 · Cited by 21
Lu, Y., Xu, K., Lin, D., Wang, S., Fu, R., Deng, X., Croppi, G., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.964429 · Cited by 19
“These findings were consistent with those of other aging-related studies (Liang et al., 2017; Walker et al., 2022) and implied that neuroinflammationrelated pathways are activated in the aged hippocampus.”
BackgroundResultAlcalde‐Estévez, E., Moreno-Piedra, A., Asenjo‐Bueno, A., Martos-Elvira, M., de la Serna-Soto, M., Ruiz‐Ortega, M., Olmos, G., López‐Ongil, S., & Ruiz‐Torres, M. P. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123507 · Cited by 16
Singh, J., Jackson, K. L., Tang, F. S., Fu, T., Nowell, C. J., Salimova, E., Kiriazis, H., Ritchie, R. H., Head, G. A., Woodman, O. L., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202301802r · Cited by 18
“10 Previous attempts to treat cardiovascular diseases by suppressing inflammation have met with limited success.”
BackgroundShafqat, A., Masters, M. C., Tripathi, U., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102400 · Cited by 15
Moaddel, R., Ubaida‐Mohien, C., Tanaka, T., Tian, Q., Candia, J., Moore, A. Z., Lovett, J., Fantoni, G., Shehadeh, N., Turek, L., et al. (2023) · Aging Cell · doi:10.1111/acel.13902 · Cited by 16
“Mitochondria are a central hub for several age-associated mechanisms, including inflammation, autophagy, cellular senescence, and genomic stability (Walker et al., 2022).”
BackgroundInfluentialSelf-citationMoaddel, R., Farmer, C., Yavi, M., Kadriu, B., Zhu, M., Fan, J., Chen, Q., Lehrmann, E., Fantoni, G., De, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108527 · Cited by 18
“55”
Self-citationVeres, T., Kerestély, M., Kovács, B. M., Keresztes, D., Schulc, K., Seitz, E., Vassy, Z., Veres, D. V., & Csermely, P. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05112-7 · Cited by 22
“Ageing can be perceived as a cumulative result of the continuous stress by free radicals and other harmful effects inducing inflammation [82–86].”
BackgroundImmunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan
Fetarayani, D., Kahdina, M., Waitupu, A., Pratiwi, L., Ningtyas, M. C., Adytia, G. J., & Sutanto, H. (2025) · Medical Sciences · doi:10.3390/medsci13030100 · Cited by 28
“Inflammaging also accelerates immunosenescence, weakening the immune response to infections and vaccinations [111].”
Blood Biomarkers for Healthy Aging
Ubaida‐Mohien, C., Tanaka, T., Tian, Q., Moore, A. Z., Moaddel, R., Basisty, N., Simonsick, E. M., & Ferrucci, L. (2023) · Gerontology · doi:10.1159/000530795 · Cited by 14
“Comparison of results from studies of aging proteome has identi fi ed over 200 proteins consistently associated with age across different assessment methods and in different tissues (i.e., blood vs. muscle) [31 – 33].”
Self-citationTranslating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Dey, A. K., Banarjee, R., Boroumand, M., Rutherford, D. V., Strassheim, Q., Nyunt, T., Olinger, B., & Basisty, N. (2023) · Biology · doi:10.3390/biology12101301 · Cited by 14
Self-citationLaskow, T. C., Langdon, J. M., Sepehri, S., Davalos-Bichara, M., Varadhan, R., & Walston, J. D. (2023) · GeroScience · doi:10.1007/s11357-023-01006-x · Cited by 15
“…inflammatory markers are crucial for the identification of older adults at high risk of adverse health outcomes, for the development of CI-related clinical trial design, and for the identification of markers secreted by senescent cells as described within the emerging field of geroscience [3, 11].”
Impact of Gut Microbiota on Aging and Frailty: A Narrative Review of the Literature
Escudero-Bautista, S., Omaña-Covarrubias, A., Castro, A. T. N., Pontigo, L. L., Pérez, B. M. P., & Chávez-Mejía, A. (2024) · Geriatrics · doi:10.3390/geriatrics9050110 · Cited by 19
“The observed effects derived from cellular senescence include growth arrest and replication, resistance to apoptosis, chromatin remodeling, and metabolic reprogramming, among others [22].”
BackgroundThe transcription factor STAT3 and aging: an intermediate medium
Shi, M., Li, H., Liang, R., Lin, H., & Tang, Q. (2025) · Biogerontology · doi:10.1007/s10522-025-10193-3 · Cited by 17
“Other mechanisms in aging, cellular senescence, mitochondrial dysfunction, impaired mitophagy and DNA damage become the hubs of inflammation (Walker et al. 2022).”
Scott, K. A., Phan, T., Boukelmoune, N., Heijnen, C. J., & Dantzer, R. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.017 · Cited by 14
Molecular damage associated with ageing drives inflammation in cardiovascular disease
Herman, A. B., Candia, J., Wilson, D. M., Donegà, S., Picard, M. A., & Ferrucci, L. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01253-3 · Cited by 18
Self-citationGao, H., Wang, K., Suárez, J., Jin, Z., Rocha, K. C. E., Zhang, D., Farrell, A., Truong, T., Tekin, Y., Tan, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216344 · Cited by 14
Zhang, M., Wei, J., Sun, Y., He, C., Ma, S., Pan, X., & Zhu, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.008 · Cited by 16
Wei, C., Li, X., Yu, J. Z., Zhang, Y., & Yuan, Q. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31287 · Cited by 13
“Neuro ‐ inflammation activates microglia and enhances the aggregation of misfolded proteins, including amyloids and tau neural progenitor fiber tangles (Walker et al., 2022).”
Innate immune response in acute critical illness: a narrative review
Stiel, L., Gaudet, A., Thietart, S., Vallet, H., Bastard, P., Voiriot, G., Oualha, M., Sarton, B., Kallel, H., Bréchot, N., et al. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01355-6 · Cited by 19
“…self-debris from defective autophagy, mitophagy and ubiquitin/proteasome system [150, 151], (ii) dysbiosis [152], (iii) mitochondrial dysfunction [153–155], (iv) cellular senescence with their “senescence-associated secretory phenotype” (SASP) and tissular aging [153, 156], (v) endoplasmic…”
BackgroundThe 15‐Year Survival Advantage: Immune Resilience as a Salutogenic Force in Healthy Aging
Manoharan, M. S., Lee, G. C., Harper, N., Meunier, J. A., Restrepo, M. I., Jiménez, F., Karekatt, S., Branum, A. P., Gaitán, Á. A., Andampour, K., et al. (2025) · Aging Cell · doi:10.1111/acel.70063 · Cited by 13
“Environmental triggers can initiate this triad, thereby elevating the risk of infection, multimorbidity, and mortality (Guo et al. 2022; Liu et al. 2023; Lopez-Otin et al. 2023; Miller et al. 2024; Walker et al. 2022).”
InfluentialAging and Lifestyle Modifications for Preventing Aging‐Related Diseases
Li, Q., Zhang, H., Xiao, N., Liang, G., Lin, Y., Yang, X. Y., Yang, J., Qian, Z., Fu, Y., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402797rr · Cited by 20
Anerillas, C., Altés, G., Gresova, K., Tsitsipatis, D., Mazan-Mamczarz, K., Banarjee, R., Cunningham, A. S. G., Salamini-Montemurri, M., Yang, J.-H., Munk, R., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.05.017 · Cited by 11
Self-citationStepanov, A. D., Shishkova, D. K., Markova, V. E., Markova, Y. O., Frolov, A. V., Lazebnaya, A. A., Oshchepkova, K., Perepletchikova, D. A., Smirnova, D., Basovich, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111382 · Cited by 13
“Moreover, elevated levels of pro-inflammatory cytokines emerge as an independent trigger of endothelial dysfunction, thus creating a vicious cycle in the elderly [11,12], patients with severe COVID-19 [13,14] or sepsis [15–18], and those with multiple organ dysfunction syndrome [19].”
BackgroundFan, D., Wang, T., Xiang, J., Bai, Y., Zhang, L., & Wang, X. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283849 · Cited by 11
“8 Recently, the association between in fl ammation and cognitive function has received increasing attention.”
Mechanism of N6-Methyladenosine Modification in the Pathogenesis of Depression
Xian, Z., Tian, L., Yao, Z., Cao, L., Jia, Z., & Li, G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04614-6 · Cited by 11
Football training as a non-pharmacological treatment of the global aging population—A topical review
Mohr, M., Fatouros, I. G., Asghar, M., Buono, P., Nassis, G. P., & Krustrup, P. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1146058 · Cited by 16
“Furthermore, aging is associated with a prolonged accumulation of damage to macromolecules and cell structures that elicit a similar inflammatory response in the circulation and within solid tissues which is involved in the pathophysiology of numerous age-related conditions (Draganidis et al., 2016; Walker et al., 202…”
BackgroundBiology of Stress Responses in Aging
Maragkakis, M., Ferrucci, L., Gorospe, M., Malla, S., Hatzoglou, M., Trifunović, A., Glick, A. B., Finkel, T., Longo, V. D., Kaushik, S., et al. (2023) · doi:10.59368/agingbio.20230001 · Cited by 11
Self-citationGarcía‐García, I., Kamal, F., Donica, O., Dadar, M., & Initiative, A. D. N. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111077 · Cited by 13
“Chronic inflammation can impair microglial function, impair its ability to clear protein deposition, and contribute this way to brain atrophy and neurodegeneration (Walker et al., 2022).”
Bioinformatics analysis of shared biomarkers and immune pathways of preeclampsia and periodontitis
Ruan, F., Wang, Y., Xiang, Y., Liu, Y., Xu, J., Zhao, H., Zhu, Y., Wen, P., Li, X., Zhou, Q., et al. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07277-w · Cited by 10
“…PE Preeclampsia, PPI Protein–protein interaction plays a pivotal role in the occurrence and progression of both PE and PD, with potential modulatory mechanisms related to inflammatory reactions, aberrant phenotypes and functions of immune cells, and cytokine and immune imbalances [11, 34, 35].”
Shishkova, D. K., Markova, V. E., Markova, Y. O., Sinitsky, M. Y., Sinitskaya, А. V., Матвеева, В. Г., Torgunakova, E., Lazebnaya, A. A., Stepanov, A. D., & Kutikhin, A. G. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604064 · Cited by 15
Kacemi, R., & Campos, M. G. (2024) · Molecules · doi:10.3390/molecules29245893 · Cited by 12
Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in Octogenarians
Ubaida‐Mohien, C., Moaddel, R., Spendiff, S., MacMillan, N. J., Filion, M., Morais, J. A., Candia, J., Fitzgerald, L. F., Taivassalo, T., Coen, P. M., et al. (2025) · Aging Cell · doi:10.1111/acel.70002 · Cited by 11
Self-citationRed ginseng extract enhances mitochondrial function and alleviates immunosenescence in T cells
Lee, H. Y., Tian, J., Nga, H. T., Nguyen, T. L., Moon, J. S., Jang, H. J., Abdillah, A. M., Lee, J., Ju, S. H., Lee, S. H., et al. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.05.004 · Cited by 11
“During aging process, immune cells tend to exhibit nonspecific activation due to mitochondrial dysfunction, contributing to augmentation of proinflammatory senescence-associated secretory phenotype, which leads to immune aging and chronic low-grade inflammation, known as inflammaging [25].”
Narendra, R., Phan, H. V., Patterson, S. L., Almonte-Loya, A., Lanata, C., Love, C., Park, J., Lydon, E., Shimoda, M., Barcellos, L. F., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adt5550 · Cited by 8
Unveiling the link: aging and its impact on ocular diseases
Wang, K., Xie, Y., Lin, Y., Zhu, R., Gao, T., Han, Z., Yang, Z., Jiang, X., Chen, H., Wu, Z., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110551 · Cited by 13
Roy, N. V., & Speeckaert, M. M. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14101054 · Cited by 10
Li, X., Wang, F., Guo, R., Liu, Y., Wu, Z., Han, Y., Zhao, W., Xin, S., & Li, B. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.02.004 · Cited by 10
Global research trends in inflammaging from 2005 to 2024: a bibliometric analysis
Jiang, B., Dong, Y.-N., Xiong, Y., Jiang, C., Ping, J., Wu, Q., Xu, L.-J., Shu, R.-Z., Gao, D., Zhu, S., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1554186 · Cited by 10
Li, M., Xu, S., Cai, H., Xiao, J., & Qin, Y. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156547 · Cited by 9
Maejima, Y., Yokota, S., Yamachi, M., Hidema, S., Ono, T., Taira, S., Nishimori, K., de Wet, H., & Shimomura, K. (2025) · Aging Cell · doi:10.1111/acel.70198 · Cited by 8
Mitochondrial quality control in human ageing and longevity
Picca, A., & Ferrucci, L. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01563-3 · Cited by 13
“However, if the quantity of released ox-CL is high, it becomes a damage-associated molecular pattern that activates Toll-like receptor 4 (TLR4)/CD36 and the NLRP3 inflammasome, linking mitochondrial distress to systemic inflammation and the inflammatory phenotype of ageing 129 .”
Self-citationZou, M., Wang, D., Chen, Y., Yang, C. H., Xu, S., & Dai, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117212 · Cited by 9
Sharma, S., Gilberto, V. S., Rask, J. C., Chatterjee, A., & Nagpal, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00160 · Cited by 11
Zhan, Y., Yang, R., Feng, J., Bai, G., Shi, X., Zhang, J., & Zhang, J. (2025) · BMC Public Health · doi:10.1186/s12889-025-21430-2 · Cited by 11
“Senescent cells secrete cytokines, chemokines and other inflammatory mediators, known as the senescence-associated secretory phenotype (SASP), to trigger a proinflammatory state in blood and solid tissues [20].”
Cacciatore, S., Calvani, R., Prokopidis, K., Schlögl, M., Russo, A., Tosato, M., Anton, S. D., Leeuwenburgh, C., Batsis, J. A., Marzetti, E., et al. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113026 · Cited by 7
Zhang, J., Wang, X.-Y., Yang, S., Xie, X., Pan, S.-J., Xu, X., & Li, Y. (2024) · Food & Function · doi:10.1039/d4fo01241k · Cited by 7
Novel Dietary Inflammatory Score and Risk of Incident CKD
Kim, H., Yin, Y., Steffen, L. M., Lutsey, P. L., Grams, M. E., Walker, K. A., Ugoji, C. C., Matsushita, K., & Rebholz, C. M. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000635 · Cited by 7
“Given the complex and multifaceted nature of in fl ammation, 17 the reliance on a handful of in fl ammatory proteins for DII and EDII development may have resulted in a limited ability to predict the overall in fl ammatory potential of diet.”
Self-citationCatalogna, M., Somerville, Y., Saporta, N., Nathansohn-Levi, B., Shelly, S., Edry, L., Zagoory‐Sharon, O., Feldman, R., & Amedi, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-91457-3 · Cited by 9
Monroy, E., Aguilar‐Hernández, L., de la Cruz‐López, F., Flores, G., & Morales‐Medina, J. C. (2025) · Brain Structure and Function · doi:10.1007/s00429-025-03002-7 · Cited by 8
Metadata
- Authors
- Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L.
- Affiliations
- National Institutes of Health (US)
- Hasselt University (BE)
- Corresponding author
- Ferrucci, Luigi
- Venue
- Journal of Clinical Investigation
- Published
- 2022-07-15
- Volume
- 132
- Issue
- 14
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC9282936
- OpenAlex
- W4285385649
- Cited by
- 189
- References
- 189
- Citations by year
- 2026: 39 · 2025: 61 · 2024: 47 · 2023: 36 · 2022: 6
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Document Server@UHasselt (UHasselt) (submittedVersion, other-oa)
- Funders
- Office of Dietary Supplements
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- inflammaging, aging, cellular senescence, mitochondrial dysfunction, mitophagy, DNA damage, hallmarks of aging, multi-omics, brain aging, neurodegenerative diseases, anti-inflammatory therapy
- MeSH terms
- Aging, Biology, DNA Damage, Humans, Inflammation, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.